Page 21 - 82_03

approaches for predicting genomic evolution. Nat
Rev Genet 2011; 12: 591-602.
8. Novembre J, Galvani AP, Slatkin M. The geographic
spread of the CCR5 ?32 HIV-resistance allele. PLoS
Biol 2005; 3: e339.
9. Stedman HH, Kozyak BW, Nelson A, Thesier DM, et
al. Myosin gene mutation correlates with anatomical
changes in the human lineage. Nature 2004; 428: 415-
18.
10. Wang X, Grus WE, Zhang J. Gene losses during
human origins. PLoS Biol 2006; 4: e52.
11. López C, Saravia C, Gómez A, Hoebeke J, Patarroyo
MA. Mechanisms of genetically-based resistance to
malaria. Gene 2010; 467: 1-12.
12. Hedrick PW. Population genetics of malaria resistance
in humans. Heredity 2011; 107: 283-304.
13. Yamamoto F, Clausen H, White T, Marken J,
Hakomori S. Molecular genetic basis of the histo-
blood group ABO system. Nature 1990; 345: 229-33.
14. Schauer R, Malykh YN, Krisch B, Gollub M, Shaw L.
Biosynthesis and biology of N-glycolilneuraminic
acid. En: Inoue Y, Lee YC, Troy FA II Eds.
Sialobiology and Other Novel Forms of Glycosilation.
Osaka. Japón: Gakushin Publishing Co. 1999: pp. 17-
27.
15. Ghaderi D, Springer SA, Ma F, Cohen M, et al. Sexual
selection by female immunity against paternal
antigens can fix loss of function alleles. Proc Natl
Acad Science 2011; 108: 17743-8.
16. Chou HH, Hayakawa T, Díaz S, Krings M, Indriati E,
et al. Inactivation of CMP-N-acetylneuraminic acid
hydroxylase occurred prior to brain expansion during
human evolution. Proc Natl Acad Sci USA 2002; 99:
11736–41.
17. a) Hoyle F, Wickramasinghe Ch. Evolution from
Space. A Theory of Cosmic Creationism. Touchstone
1984; ISBN 0-671-49263-2. b) Altwegg K, BalsigerH,
Bar-Nun A, Berthelier J-J. Prebiotic chemicals-amino
acid and phosphorus- in the coma of comet
67P/Churyumov-Gerasimenko. Sci Adv 2016; 2:
e1600285.
18. a) Hayakawa T, Aki I, Varki A, Satta Y, Takahata N.
Fixation of the human-specific CMP-N-
acetylneuraminic acid hydroxylase pseudogene and
implications of haplotype diversity for human
evolution. Genetics 2006; 172: 1139–46. b) Varki A.
Multiple changes in sialic acid biology during human 32. a) Klurfeld DM. Research gaps in evaluating the
evolution. Glycoconjugate Journal 2009; 26: 231–45.
19. Tuppy H, Gottschalk A. Isolation and purification of
sialic acids. In: Gottschalk A, Ed. Glycoproteins,
Their Composition, Structure and Function.
Amsterdam: Elsevier 1972; pp. 403-49.
20. Kitajima K, Sato Ch. The Roles of Carbohydrate
Binding in Cell Adhesion and Inflammation. In: Wang
B, Boons G-J Eds. Carbohydrate Recognition.
Biological problems, methos and applications. New
York: John Wiley & Sons 2011; pp. 33-63.
280
M.ª del Carmen Avendaño López
21. Angata T, Varki A. Chemical Diversity in the Sialic
Acids and Related a-Keto Acids:? An Evolutionary
Perspective. Chem Rev 2002; 102: 439–70.
22. Cornish-Bowden A, Barrett AJ, Cammack R, Chester
MA, et al. Nomenclature of glycolipids. Carbohyd
Res 1998; 312: 167-75.
23. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi
MA, Samyn-Petit B, Julien S, Delannoy P. The human
sialyltransferase family. Biochimie 2001; 83: 727-37.
24. Coefield AP, Veh RW, Wember M, Megasilk JC,
Achauer R. The release of N-acetyl- and N-glycolyl-
neuraminic acid from soluble complex carbohydrates
and erythrocytes by bacterial, viral and mammalian
sialidases. Biochem J 1981; 197: 293-99.
25. Reglero A, Bravo IG, Fernández-Martínez V. Ácidos
siálicos: distribución, metabolismo y función
biológica. An R Acad Nac Farm 2007; 73: 833-71.
26. a) Lenard J, Comans RW. The membrane structure of
lipid-containing viruses. Biochim Biophys Acta 2007;
344: 51-94. b) Shiraishi H, Kohoma T, Shipaishi R,
Ishida N. Carbohydrate composition of hepatitis B
surface antigen. J Gen Virol 1977; 36: 207-210.
27. Gubareva L, Kaiser L, Hayden FG. Influenza virus
neuraminidase inhibitors. The Lancet 2000; 355: 827-
35.
28. Kyogashima M, Ginsburg V, Krivan HC. Escherichia
coli K99 binds to N-glycolylsialoparagloboside and N-
glycolyl-GM3 found in piglet small intestine”. Archiv
Biochem Biophys 1989; 270: 391-97.
29. a) Irie A, Koyama S, Kozutsumi Y, Kawasaki T,
Suzuki A. The molecular basis for the absence of N-
glycolylneuraminic acid in humans. J Biol Chem
1998; 273: 15866-71. b) Varki A. Loss of N-
Glycolylneuraminic Acid in Humans: Mechanisms,
Consequences, and Implications for Hominid
Evolution. Yearbook of Physical Anthropology 2001;
44: 54–69.
30. Tangvoranuntakul P, Gagneux P, DiazS, BardorM, et
al. Human uptake and incorporation of an
immunogenic nonhuman dietary sialic acid. PNAS
2003; 100: 12045-50.
31. Samraj AN, Pearce OMT, Läubli H, Crittenden AN, et
al. A red meat-derived glycan promotes inflammation
and cancer progression, PNAS 2015; 11: 542-47.
relationship of meat and health. Meat Sci. 2015; 109:
86-95. b) Celada P, Sánchez-Múniz FJ. Are meat and
meat product consumptions harmful? Their
relationship with the risk of colorectal cancer and
other degenerative diseases”. An R Acad Farm 2016;
82: 68-90.
33. Bouvard V, Loomis D, Guyton KZ, Grosse Y, El
Ghissassi, et al. Carcinogenicity of consumption of
red and processed meat. The Lancet Oncol 2015; 16:
1599-1600.
34. Lopez-García E, Schulze MB, Fung TT, Meigs JB, et
al. Major dietary patterns are related to plasma
@Real Academia Nacional de Farmacia. Spain